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Abstract
Background: Subventricular microglia (SVMs) are positioned at the interface of the cerebrospinal
fluid and brain parenchyma and may play a role in periventricular inflammatory reactions. However,
SVMs have not been previously investigated in detail due to the lack of a specific methodology for
their study exclusive of deeper parenchymal microglia.
Methods:  We have developed and characterized a novel model for the investigation of
subventricular microglial reactions in mice using intracerebroventricular (ICV) injection of high-
dose rhodamine dyes. Dynamic studies using timelapse confocal microscopy in situ complemented
the histopathological analysis.
Results: We demonstrate that high-dose ICV rhodamine dye injection resulted in selective uptake
by the ependyma and ependymal death within hours. Phagocytosis of ependymal debris by activated
SVMs was evident by 1d as demonstrated by the appearance of rhodamine-positive SVMs. In the
absence of further manipulation, labelled SVMs remained in the subventricular space. However,
these cells exhibited the ability to migrate several hundred microns into the parenchyma towards
a deafferentation injury of the hippocampus. This "infiltrative microgliosis" was verified in situ using
timelapse confocal microscopy. Finally, supporting the disease relevance of this event, the triad of
ependymal cell death, SVM activation, and infiltrative microgliosis was recapitulated by a single ICV
injection of HIV-1 tat protein.
Conclusions: Subependymal microglia exhibit robust activation and migration in periventricular
inflammatory responses. Further study of this population of microglia may provide insight into
neurological diseases with tendencies to involve the ventricular system and periventricular tissues.
Background
It has become increasingly evident that the central nerv-
ous system is an immunocompetent organ [1]. Microglia
are the primary immune effector cells of the brain paren-
chyma and functionally resemble tissue macrophages
elsewhere in the body [1,2]. The brain ventricles are also
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under immune surveillance by intraventricular macro-
phages which patrol the cerebrospinal fluid (CSF),
choroid plexus, and supraependymal surface [3]. At the
interface of the CSF and brain proper is the ciliated neu-
roepithelial ependymal cell which lines the ventricular
system of the brain and spinal canal. The ependyma not
only functions as a physical barrier preventing foreign
proteins and organisms from entering the brain from the
CSF, but also displays immunological effector ability such
as phagocytosis of fluorescent beads injected into the CSF
[4] and upregulation of MHC-II in response to interferon
gamma challenge in vivo [5]. These diverse cell types may
work in concert establishing the basis for the innate
immune system of the CNS.
Importantly, a population of resident subventricular
microglia (SVMs) are found in the subependymal zone
[6,7] suggesting the ependyma and microglia may cooper-
ate to prevent invasion of the CNS from the ventricular
system. Juxtaventricular microglia have been shown to
react to both direct periventricular/ependymal damage as
well as the mere presence of cytokines in the CSF. For
instance, the intracerebroventricular (ICV) injection of
lentiviral tat protein in low nanomolar quantities is suffi-
cient to kill ependymal cells and cause a periventricular
inflammatory reaction including the characteristic micro-
glial nodules of human HIV-1 encephalopathy (HIVE)
[8]. Alternatively, Kong et al [9], noting the high CSF lev-
els of inflammatory cytokines in multiple sclerosis (MS),
demonstrated a vigorous periventricular activation of
microglia with ICV injection of IFN-γ alone or in combi-
nation with endotoxin or TNF-α. In these cases, microglia
were activated in the absence of primary tissue damage,
but were thought to contribute secondarily to immune-
mediated periventricular damage via potentiation of
cytokine release and bystander effect. Of note, both HIVE
and MS often present with enigmatic periventricular
inflammatory lesions in humans [10-13].
The reaction of SVMs to periventricular damage has not
been described in detail. Specifically, the functional reper-
toire displayed by activated SVMs including phagocytosis
and long-distance migration have not been investigated.
Here, we directly examine SVM function by exploiting a
novel methodology which selectively activates and labels
SVMs  in vivo combined with confocal timelapse tech-
niques for dynamic analyses in adult mouse brain tissue.
We hypothesized that SVM activation is a general conse-
quence of periventricular insults that can be caused by
diverse circulating substances in the CSF known to dam-
age the ependyma. Our work indicates that activated,
phagocytic SVMs are capable of infiltrating deep within
the parenchyma.
Methods
Animals
Adult male C57bl/6 mice (6–8 wks) were obtained com-
mercially from Harlan (Indianapolis, IN) and cared for in
accordance with Public Health Service and University of
Virginia guidelines.
Surgical procedures
To damage the ependyma 2–3 µl of 0.2% Sp-DiI (D-7777,
Molecular Probes) in DMSO; 1:20 rhodamine-conjugated
latex microspheres (Lumafluor, Naples, FL) in sterile PBS;
0.25 U Neuraminidase (Sigma); or 2.0 nM recombinant
HIV-1 tat protein in 100 mg/ml BSA, 0.1 mM DTT in PBS
were stereotaxically injected into the left lateral ventricle
at the following coordinates: L, 1.5 mm; P, -0.5 mm; D,
2.0 mm. GFP-expressing adenovirus (109 plaque forming
units); 100 mg/ml BSA, 0.1 mM DTT in PBS, or deacti-
vated tat [14] were used as volume-matched controls.
Forebrain stab lesion for deafferenting lesion of the con-
tralateral hippocampus was performed as previously
described [15]. Briefly, mice were anesthetized with a
Xylazine/Ketamine mixture and placed in a stereotaxic
head holder (Benchmark, myneurolab.com). Tempera-
ture was maintained with a ventral heat pad. A right pari-
etal craniectomy extending 3–4 mm from midline and
spanning Lambda to Bregma was created with a micro-
drill. Beginning at the level of Bregma, a 3 mm lesion was
created in the sagittal plane 1.5 mm from midline at a
depth of 3.5 mm with a sterile no. 11 scalpel blade held
in the stereotaxic device. After achieving hemostasis, the
bone was replaced and sealed with carboxylate cement
(Durelon, Fisher Sci). This right sided lesion results in
deafferentation injury to primarily stratum oriens of the left
hippocampus.
Static analyses
Brains were collected and processed for histopathology as
previously described [15]. All antibodies and staining pro-
cedures have been described previously [15] except for rat
anti-cd11b/MAC-1 (1:50), mouse anti-foxj1 (1:1000),
mouse anti-nestin/rat-401 (1:100), and rat anti-F4/80
(1:10). Histochemistry for biotinylated Griffonia simplici-
folia lectin IB4 was performed 1:100 in PBS overnight at
4°C and visualized with either 1:200 FITC- or Alexa Fluor
350-conjugated streptavidin (Sigma and Molecular
Probes, respectively).
Dynamic analyses
200–400 µm live slices were prepared from adult C57BL/
6 mice as described previously [16,17]. Briefly, mice were
acutely anesthetized in a chamber with halothane and
decapitated. The brain was rapidly removed, blocked, and
covered with 10% agar at 37°C in a specimen mold (Tis-
sue-Tek 4566, Fisher). Live slices were obtained with a
vibratome and placed individually on Millicell-CM insertsJournal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
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(Millipore PICM03050, Fisher). Culture medium con-
sisted of CCM1 (Hyclone, Logan, UT) with 20% heat-
inactivated normal horse serum. Vital labelling of micro-
glia in tat experiments was performed with Alexa 488 or
568 IB4 (Molecular Probes) [17]. Laser-scanning confocal
images were acquired on a Nikon IX-70 inverted micro-
scope with Fluoview 300 software (Olympus). A z-series
stack covering 40 µm of slice thickness was taken every
1.5–4 minutes, creating a three-dimensional timelapse
data set. To create timelapse movies from the data set, 4 to
6 z-plane images were collapsed as 2D projections using
ImageJ 1.31 u and compiled into quicktime movies with
Quicktime Pro 6.3. Movies were analyzed for migration
speed and distance as described [18]. Values represent the
mean ± SEM. Statistical analysis was performed with
ANOVA or student's t-test. Pairwise post-hoc analysis was
performed with a t-test and the Bonferroni correction fac-
tor. A p < 0.05 was considered statistically significant. Rose
plots were created in Kaleidagraph 3.0.
Results
Selective ependymal death is induced by high-dose 
rhodamine dyes
Rhodamine dyes such as SP-DiI and rhodamine latex
microbeads (RhoB) have been classically used for tract
tracing studies in vivo and in fixed tissues [19,20].
Recently, intracerebroventricular (ICV) injection of these
dyes into the CSF has also been shown to selectively label
ependymal cells [4,21]. In pilot studies for other projects,
we discovered doses of these dyes that, in addition to
labelling, result in selective death and denudation of the
ependyma (not shown). To investigate the timecourse of
ependymal damage in response to rhodamine dyes we
injected a toxic bolus of SP-DiI (0.2% in DMSO) or rhod-
amine latex microbeads (1:20 in PBS) into the left lateral
ventricle of mice. Overt ependymal damage was appreci-
ated beginning by 12 h (Fig. 1a, left panel) post-injection
and progressed rapidly by 24 h (Fig. 1a, middle panel)
where the ependyma appeared swollen and ragged with
frequent pyknotic profiles (Fig. 1b). At these doses, dam-
age was largely restricted to the lateral ventricle ipsilateral
to the injection and the third ventricle (not shown) while
sparing the contralateral lateral ventricle (Fig. 1b, c) sug-
gesting a dose- and diffusion-dependent toxicity. Near
complete ependymal cell loss occured in regions of the
lateral ventricle proximal to the injection site within 3
days with both dyes (Fig. 1A, right panel &1D). Mild sub-
ependymal astrogliosis as revealed by nestin immunohis-
tochemistry was also evident by 3d (Fig. 1E). The loss of
ependyma was further confirmed by chronic loss of
immunoreactivity for the ciliated cell-specific transcrip-
tion factor foxj1 at 1 month after injection (Fig. 1f). Ani-
mals injected with equal volumes of GFP-reporter
adenovirus (Fig. 1g) or low-dose rhodamine microbeads
in PBS (1:50, not shown) demonstrated no ependymal
loss or activation of subventricular microglia (SVMs, not
shown). Thus, rhodamine dyes rapidly and selectively
damage ependymal cells at high doses.
SVMs phagocytose ependymal debris
Loss of the ependyma in the above areas coincided with
the appearance of dye-laden periventricular cells resem-
bling macrophages (Fig. 1d, arrowheads). At low power,
affected ventricles were surrounded by a halo of these
rhodamine-positive (RHO+) cells (Fig. 1a, last panel; 1c).
To determine the identity of the RHO+ cells we performed
transmission electron microscopy (Fig. 2a), immunohis-
tochemistry for microglial/macrophage markers F4/80
(Fig. 2b) and MAC-1/cd11b (not shown), and histochem-
istry for IB4 lectin from Griffonia simplicifolia (Fig. 2b).
These techniques demonstrated periventricular RHO+
cells to be microglia.
SVMs may become RHO+ as a result of phagocytosis of
the dye-labeled ependymal debris. To provide direct evi-
dence of this hypothesis we performed confocal time-
lapse microscopy in living slices from adult mice given
dye injection 24 h prior to sacrifice. Grossly, we observed
a dramatic increase in RHO+ periventricular cells over sev-
eral hours suggesting active clearance of labelled debris
(not shown). Further, SVMs displayed dynamic behavior
consistent with phagocytosis of ependymal debris (Fig.
2c, Video 1(Additional file 1)). Therefore, SVMs became
rhodamine positive after high-dose dye injection due to
phagocytosis of labelled ependymal debris.
To determine if SVM activation is a general response to
periventricular damage we injected animals with a suble-
thal dose of RhoB to label ependymal cells without caus-
ing damage. 24 h later we injected 0.25 U neuraminidase
to damage the ependyma [22] via an alternate mecha-
nism. Histological examination of sections at 7 d revealed
loss of the ependyma and the presence of RHO+ SVMs
(Fig. 2d, left panels). Control injection of PBS vehicle
alone resulted in no ependymal damage or SVM labelling
(Fig. 2d, right panels). Thus, ependymal cell damage of
diverse etiologies incites a reactive response by SVMs
including phagocytosis of debris.
Long-distance infiltration by SVMs after parenchymal 
injury
Unpurturbed, SVMs remained in the immediate periven-
tricular vicinity with no deeper parenchymal migration
(Fig. 1c). Indeed, his population was stable in animals
sacrificed up to 30d following dye injection (not shown).
Periventricular lesions in HIVE and MS often extend deep
into the parenchyma suggesting long-distance infiltration
of reactive cells. Microglia have been shown to migrate in
vitro in response to many chemokines and growth factors
present in brain lesions and plaques [23-26]. In order toJournal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
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investigate whether activated SVMs can migrate towards
parenchymal brain damage in vivo we gave mice a deaffer-
enting lesion (FSL) of the hippocampus 24 hours follow-
ing rhodamine dye injection and allowed survival for up
to 28 days. Invasion of the parenchyma by RHO+ cells
occurred in the stratum oriens of the denervated hippocam-
pus (cSO) in 21/21 animals but not in sham animals (0/
4) (Fig. 3a). Infiltrating cells were found an average of 849
± 34 µm from the lateral ventricle after FSL compared to
210 ± 16 µm in uninjured mice (p < 0.01, Fig. 3b). Based
on population distribution histograms, greater than 75%
Ependymal damage with rhodamine dyes Figure 1
Ependymal damage with rhodamine dyes. (A) Timecourse of 
ependymal death in the lateral ventricle after rhodamine dye 
injection demonstrated with digital subtraction. Damage to 
the ependyma was evident at 12 h and rapidly progressed by 
24 h. (B) Histology at 24 h demonstrates swollen ependyma 
with numerous pyknotic profiles in injected, but not the con-
tralateral, hemisphere. e, ependyma; lv, lateral ventricle; p, 
parenchyma. RHO fluorescence overlaid on brightfield hema-
toxylin images. (C) Low-power view of lateral ventricles 3 d 
after injection demonstrates halo of rhodamine-positive cells 
around injected ventricle (white arrow). The contralateral 
ventricle demonstrates labelled ependyma in the absence of 
damage. (D) By 3 d, near-complete loss of the ependyma was 
evident. This coincided with the appearance of dye-laden 
SVMs, black arrowheads. The ependyma remained intact in 
the contralateral hemisphere (right panels). e, ependyma; lv, 
lateral ventricle; p, parenchyma; RhoB, rhodamine beads. 
RHO fluorescence overlaid on brightfield hematoxylin image 
(RhoB) and photoconverted DiI counterstained with hema-
toxylin. (E) Periventricular reactive astrocytes (black arrows) 
visualized with nestin immunohistochemistry (IHC) at 3d 
post-injection at wall of injected ventricle (left), but not in 
the contralateral hemisphere (right). lv, lateral ventricle; sp, 
septum. (F) IHC for ciliated cell-specific foxj1 28d after dye 
injection demonstrates persistent loss of ependyma in 
injected hemispere (left). cc, corpus callosum, cp, caudate/
putamen; sp, septum. (G) Equivalent volume control injection 
of GFP-reporter adenovirus demonstrates no ependymal 
damage 3 weeks after injection. e, ependyma; lv, lateral ven-
tricle; p, parenchyma. GFP fluorescence overlaid on bright-
field hematoxylin image.
Selective labelling of SVMs with rhodamine dyes Figure 2
Selective labelling of SVMs with rhodamine dyes. (A) RHO+ 
cells are microglia. Transmission electron microscopy dem-
onstrates dye-laden inclusions (white arrows) in a SVM. n, 
nucleus. (B) Immunohistochemistry for F4/80 (top) and histo-
chemistry for lectin IB4 (bottom) demonstrate double-
labelled periventricular cells, white arrows. (C) Time-lapse 
confocal microscopy in live brain slices demonstrates SVM 
(white arrow) extending (time 0' and 9') and retracting (time 
4.5' and 13.5') a process toward ependymal debris (yellow 
star) highly suggestive of phagocytosis. See also Video 1. lv, 
lateral ventricle; p, parenchyma. (D) Neuraminidase injection 
following sublethal ependymal labelling similarly results in 
RHO+ SVMs (black arrows). e, ependyma; lv, lateral ventri-
cle; p, parenchyma. Left panels, hematoxylin; Right panels, 
RHO fluorescence overlaid on hematoxylin.Journal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
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of RHO+ cells in sham animals were found within 300
µm of the ventricles (maximum: 860 µm) whereas greater
than 75% were found beyond 400 µm (maximum: 2377
µm) in injured mice. Temporal quantification of RHO+
cell infiltration in the cSO demonstrates that this event
commences between 1 and 3 days post-injury (PI) and
peaks at 5 days PI (Fig. 3c). This timecourse mirrors that
of the appearance of degeneration debris (Fig. 3d, GSD),
activated resident hippocampal microglia (Fig. 3d, IB4),
and reactive gliosis in the cSO (Fig. 3d, pERK [15]) sup-
porting migration of RHO+ cells towards injury cues
[24,25]. 94.6% of all RHO+ cells in the cSO were immu-
noreactive for F4/80 confirming the infiltrating cells are
microglia. Finally, BrdU-positive/RHO+ cells were
observed in the cSO maximally at the 3 day timepoint sug-
gesting mitosis occurred primarily after the SVMs had
migrated to the hippocampus (not shown). Therefore,
activated SVMs are capable of infiltrating deep into the
parenchyma in response to brain injury.
To provide direct evidence for the migration of SVMs into
the parenchyma and characterize their general migratory
behavior we prepared live brain slices from dye-injected/
lesioned mice and rendered confocal time-lapse movies in
the cSO (Fig. 4a; Video 2 (Additional file 2)). RHO+ cells
migrated in a directed fashion from the periventricular
region into the cSO (Fig. 4b) and demonstrated an aver-
age speed of 80 ± 6 µm/h. Migrating cells displayed polar-
ized morphologies with a prominent leading protrusion
demonstrating numerous side branches (Fig. 4c). We con-
clude that activated SVMs are able to migrate long dis-
tances into the brain parenchyma towards damaged
regions in vivo and in situ. We have named this event "infil-
trative microgliosis" (IMG).
ICV injection of HIV-1 tat protein causes IMG
Lentiviral tat protein has been shown to be neurotoxic [8],
stimulate microglial migration in vitro possibly by mim-
icking, and inducing expression of, chemokines [27,28],
and soluble tat protein is released from HIV-infected cells
[29]. Further, ependymal lesions were found in 16% of
AIDS patients at autopsy [30] and HIV-1 tat has been
shown to damage the ependymal layer of mice in low
nanomolar concentrations [8]. To establish IMG as an
event relevant to neurologic disease we tested the idea that
ependymal damage caused by an ICV injection of 2.0 nM
recombinant HIV-1 tat protein in mice would cause acti-
vation, and possibly intraparenchymal migration, of
SVMs. 24 hours post-injection mice demonstrated epend-
ymal cell damage (Fig. 5a, top left) and extensive activa-
tion of SVMs (Fig. 5a, bottom left). No damage or SVM
activation was seen after injection of deactivated tat (Fig.
5a, right panels). Interestingly, activated microglia could
often be found several hundred microns from ventricular
surfaces as demonstrated by IB4  histochemistry (not
shown). To determine whether this was due to migration
of SVMs into the parenchyma or spreading activation of
stationary cells we performed timelapse confocal analysis
of live brain slices taken from animals 24 h after ICV tat
injection. We found that nearly all activated periventricu-
lar microglia were motile and many were locomotory after
tat injection (Video 3 (Additional file 3). Injection of
deactivated tat did not result in migration (Video 4
Infiltration of parenchyma by SVMs after injury Figure 3
Infiltration of parenchyma by SVMs after injury. (A) SVMs 
infiltrated the stratum oriens of the hippocampus in injured 
mice (right panel) but not in sham animals (left panel). cSO, 
contralateral stratum oriens of hippocampus; ffx, fimbria/for-
nix; lv, lateral ventricle; th, thalamus. (B) SVMs migrate signif-
icantly farther into parenchyma of injured animals compared 
to sham injury (*p < 0.01). (C) Infiltration of hippocampus 
begins days after injury and cells remain for weeks (*p < 0.05 
compared to sham). (D) Temporal pattern of infiltration cor-
responds to neuropil degeneration (black punctate staining, 
bottom left) activation of resident microglia (shown by 
increased IB4 staining, bottom middle) and glial activation 
(indicated by phospho-ERK immunoreactivity, bottom right). 
GSD, Gallyas silver degeneration stain; pERK, phospho-
extracellular signal-related kinase.Journal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
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(Additional file 4)). Velocities of HIV-1 tat activated
microglia averaged approximately 500 µm/h. Further, we
observed many microglia which migrated deep into the
parenchyma from the periventricular zone (Fig. 5b, Video
5 (Additional file 5)). Intense microglial activity at the
ependyma suggestive of phagocytosis was also observed
(Video 5). We conclude that nanomolar concentrations of
ICV-injected HIV-1 tat protein alone is sufficient to cause
ependymal damage, SVM activation, and diffuse IMG.
Discussion
We have shown that SVMs represent a pool of microglial
cells which are highly reactive to periventricular damage
and are responsible for clearance of resulting cellular
debris. Further, activated SVMs are capable of migrating
away from the ventricle towards injury cues from dam-
aged regions in the parenchyma several hundred microns
away. We confirmed these findings dynamically in acute
slice preparations from adult mice. Both the
juxtaventricular origin and the extensive migratory capac-
ity of activated SVMs have important implications for
neurobiology and disease.
Periventricular/subependymal microglia have been noted
by histologists since microglia were first identified as a
distinct cell type (reviewed in [31]). Little attention has
been paid to these cells in the literature until recently due
to their intimate arrangement among the subventricular
Dynamics of infiltrative microgliosis Figure 4
Dynamics of infiltrative microgliosis. (A) 2D projections of 
confocal images demonstrate three migratory cells (large and 
small white arrows) migrating into the cSO. white arrow-
head, non-migratory cell for reference. e, ependyma; cSO, 
stratum oriens. See also Video 2. (B) Migration was highly 
directed from ventricle to hippocampus, five representative 
cells from a single experiment. lv, lateral ventricle; black 
stars, cell origin (C) Highly polarized, migratory morpholo-
gies of RHO+ cells as demonstrated by confocal 3D recon-
struction. cb, cell body; lpr, leading process; tpr, trailing 
process.
HIV-1 tat injection activates SVMs and incites IMG Figure 5
HIV-1 tat injection activates SVMs and incites IMG. (A) 
Ependymal loss (top left) and subventricular microgliosis 
(bottom left) 24 h following injection of 2.0 nmol tat protein 
but not in animals injected with deactivated tat (right panels). 
(B) To determine if tat-activated SVMs migrated in situ we 
rendered timelapse confocal movies 24 h post-injection. 
Colored arrowheads demonstrate three SVMs which migrate 
from the region near the ventricle (green line) deep into the 
parenchyma (colored dashed lines). Field measures ~200 µm 
horizontally. See also Video 5.Journal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
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neural progenitors [6,7]. Possible phenotypic differences
between SVMs and parenchymal microglia have not been
investigated, however, the location of SVMs among stem
cells and within close proximity to ependymal cells and
ventricular CSF is unique. A few neurological diseases
demonstrate altered CSF constituents and often patholog-
ical involvement of the periventricular tissues [8-13].
Therefore, the specific function of microglia in these
specialized regions of the brain under normal and patho-
logical conditions deserve further investigation.
While evaluating rhodamine dyes for selective labeling of
ependymal cells [21] for other studies we discovered that
the ependyma of the injected hemisphere became rapidly
damaged after dye uptake. Upon death of the ependyma,
SVMs phagocytosed the ependymal debris, and thereby
became rhodamine-positive. This serendipitous finding
results in rapid and selective labelling of SVMs allowing
study of this specific cell population in vivo. For instance,
in this study we were able to demonstrate phagocytosis,
mitosis, and migration of activated SVMs using his-
topathological techniques alone. We have shown these
cellular activities can be confirmed in situ with timelapse
confocal microscopy further validating this versatile pro-
tocol. Mechanistic investigations are possible by combin-
ing our in vivo and  in situ protocols with genetic or
pharmacological techniques.
We found SVMs only infiltrated the brain after selective
ependymal damage with rhodamine dyes if a distant
lesion was also present, likely providing a gradient of che-
moattractive cues. CC chemokines are known to be upreg-
ulated rapidly after deafferenting injury of the
hippocampus [26]. The extensive migration of SVMs in
response to HIV-tat injection, on the other hand, may be
due to a direct effect of tat on microglia or possibly an
indirect effect due to upregulation of chemokines by neu-
rons and glia [27,28]. Further, that ICV injection of
recombinant HIV-1 tat protein alone is sufficient to dam-
age the ependyma, activate SVMs, and incite infiltrative
microgliosis supports the "cytokine dysregulation
hypothesis" [8,22] of damage in HIV-1 encephalitis
whereby overactivation of microglia/monocytes may be
more critical than actual CNS viral load [33,34].
Conclusions
In summary, we have shown that SVMs are a highly reac-
tive pool of cells which, when activated, can infiltrate the
parenchyma in response to injury cues from damaged
brain regions or exposure to HIV-1 tat. These findings
provide new in vivo and in situ models for the study of
SVM function, further insight into microglial dynamics
after brain injury, and novel hypotheses for the role of
microglia in periventricular reactions in neurological
diseases.
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phagocytosis of dye-labeled ependymal cell debris 24 h following injection. 
SVMs can be seen extending processes towards debris. Examples of epend-
ymal debris are pseudocolored yellow. Each frame is a 2D projection rep-
resenting a stack of 6 images 8 µm apart. Original magnification, 40×.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
2094-2-5-S1.MOV]
Additional File 2
Dynamics of infiltrative microgliosis. Infiltrative microgliosis of SVMs 
into the hippocampal stratum oriens from the subependymal region of 
the posterior lateral ventricle. Note highly directed migration into the hip-
pocampus. Each frame is a 2D projection representing a stack of 4 images 
10 µm apart taken every 3 minutes. Original magnification, 20×.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
2094-2-5-S2.MOV]Journal of Neuroinflammation 2005, 2:5 http://www.jneuroinflammation.com/content/2/1/5
Page 8 of 9
(page number not for citation purposes)
Acknowledgments
We thank Stephen Brody (Washington University) for the gift of foxj1 anti-
bodies; Rooshin Dalal and Claire Brown for expert assistance with confocal 
microscopy; John Stock for expert assistance with electron microscopy, 
Sean Aeder and Isa Hussaini for the gift of the Ad-GFP; Isa Hussaini, Akira 
Sakakibara, and Scott Vandenberg for helpful discussion; and Margo Rob-
erts for comments on this manuscript. The following reagents were 
obtained through the NIH AIDS Research and Reference Reagent Program, 
Division of AIDS, NIAID, NIH: TAK-779 and HIV-1 Tat protein from Dr. 
John Brady and DAIDS, NIAID. This research was supported by National 
Institutes of Health Grants NS-047378 (to J.W.M.) and GM-232442 and 
GM-064346 (to A.F.H.). W.S.C. was supported by the UVA Medical Scien-
tist Training Program, a Raven Society Fellowship, and an award from the 
National Neurotrauma Society.
References
1. Becher B, Prat A, Antel JP: Brain-immune connection: immu-
noregulatory properties of CNS-resident cells.  Glia 2000,
29:293-304.
2. Kreutzberg GW: Microglia: a sensor for pathological events in
the CNS. Trends Neurosci 1996, 19:312-318.
3. Ling E A, Kaur C, Lu J: Origin, nature and some functional con-
siderations of intraventricular macrophages, with special
reference to the epiplexus cells. Microsc Res Tech 1998, 41:43-56.
4. Doetsch F, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A: Subven-
tricular zone astrocytes are neuronal stem cells in the adult
mammalian brain. Cell 1999, 97:703-716.
5. Steiniger B, van der Meide PH: Rat ependyma and microglia cells
express class II MHC antigens after intravenous infusion of
recombinant gamma interferon.  J Neuroimmunol 1988,
19:111-118.
6. Lewis PD: The fate of the subependymal cell in the adult rat
brain, with a note on the origin of microglia.  Brain 1968,
91:721-736.
7. Mercier F, Kitasako JT, Hatton GI: Anatomy of the brain neuro-
genic zones revisited: Fractones and the fibroblast/macro-
phage network. J Comp Neurol 2002, 451:170-188.
8. Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G,
Metzger D, Roubin R, Filippi P: The basic domain of the lentiviral
tat protein is responsible for damages in mouse brain:
Involvement of cytokines. Virology 1994, 205:519-529.
9. Kong GY, Kristensson K, Bentivoglio M: Reaction of mouse brain
oligodendrocytes and their precursors, astrocytes and
microglia, to proinflammatory mediators circulating in the
cerebrospinal fluid. Glia 2002, 37:191-205.
10. Nelson PT, Soma LA: Microglia in diseases of the central nerv-
ous system. Ann Med 2002, 34:491-500.
11. Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA:
Encephalitis caused by human immunodeficiency virus: CT
and MR imaging manifestations with clinical and pathologic
correlation. Radiology 1990, 175:185-191.
12. Benveniste EN: Role of macrophages/microglia in multiple
sclerosis and experimental allergic encephalomyelitis. J Mol
Med 1997, 75:165-173.
13. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE:
Nuclear magnetic resonance imaging of the brain in multiple
sclerosis. Lancet 1981, 2:1063-1066.
14. Faneles-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro
A, Ensoli B: Native HIV-1 tat protein targets monocyte-
derived dendritic cells and enhances their maturation, func-
tion, and antigen-specific T cell responses.  J Immunol 2002,
168:197-206.
15. Carbonell WS, Mandell JW: Transient neuronal but persistent
astroglial activation of ERK/MAP kinase after focal brain
injury in mice. J Neurotrauma 2003, 20:327-336.
16. Murase S-I, Horwitz AF: Deleted in colorectal carcinoma and
differentially expressed integrins mediate the directional
migration of neural precursors in the rostral migratory
stream. J Neurosci 2002, 22:3568-3579.
17. Stence N, Waite M, Dailey ME: Dynamics of microglial activa-
tion: a confocal time-lapse analysis in hippocampal slices. Glia
2001, 33:256-266.
18. Knight B, Laukaitis C, Akhtar N, Hotchin NA, Edlund M, Horwitz AR:
Visualizing muscle cell migration in situ.  Curr Biol 2000,
10:576-585.
19. Godement P, Vanselow F, Thanos S, Bonhoeffer F: A study in devel-
oping visual systems with a new method of staining neurones
and their processes in fixed tissue.  Development 1987,
101:697-713.
20. Katz LC, Burkhalter A, Dreyer WJ: Fluorescent latex micro-
spheres as a retrograde neuronal marker for in vivo and in
vitro studies of visual cortex. Nature 1984, 310:498-500.
21. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J:
Identification of a neural stem cell in the adult mammalian
central nervous system. Cell 1999, 96:25-34.
22. Grondona JM, Perez-Martin M, Cifuentes M, Perez J, Jimenez AJ,
Perez-Figares JM, Fernandez-Llebrez P: Ependymal denudation,
aqueductal obliteration and hydrocephalus after a single
injection of neuraminidase into the lateral ventricle of adult
rats. J Neuropath Exp Neurol 1996, 55:999-1008.
23. Bajetto A, Bonavia R, Barbero S, Schettini G: Characterization of
chemokines and their receptors in the central nervous sys-
tem: physiopathological implications.  J Neurochem 2002,
82:1311-1329.
24. Nolte C, Kirchhoff F, Kettenmann H: Epidermal growth factor is
a motility factor for microglial cells in vitro: evidence for EGF
receptor expression. Eur J Neurosci 1997, 9:1690-1698.
25. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K,
Stella N: Nonpsychotropic cannabinoid receptors regulate
microglial cell migration. J Neurosci 2003, 23:1398-1405.
26. Babcock AA, Kuziel WA, Rivest S, Owens T: Chemokine expres-
sion by glial cells directs leukocytes to sites of axonal injury
in the CNS. J Neurosci 2003, 23:7922-7930.
Additional File 3
SVM dynamics in response to HIV-1 tat protein. Extensive migratory acti-
vation of periventricular microglia in response to 2.0 nM ICV HIV-1 tat 
protein. This migratory reaction extends several hundred microns into the 
parenchyma. v3v, ventral third ventricle. Each frame is a 2D projection 
representing a stack of 6 images 8 µm apart taken every 90 seconds. Orig-
inal magnification, 20×. Field measures 700 × 700 µm.
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Additional File 4
Control video for HIV-1 tat protein. Lack of activation of SVMs and 
migration with ICV injection of deactivated HIV-1 tat protein (compare 
to Video 3, similar field). The paucity of IB4 labeling indicates the limited 
microglial activation. Note blood vessel endothelial cell labeling and grad-
ual photobleaching. Each frame is a 2D projection representing a stack of 
6 images 8 µm apart taken every 90 seconds. Original magnification, 
20×. Field measures 700 × 700 µm.
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[http://www.biomedcentral.com/content/supplementary/1742-
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Additional File 5
HIV-1 tat incites infiltrative microgliosis. HIV-1 tat activated subven-
tricular microglia infiltrate the parenchyma. Three highlighted cells corre-
spond to those in Figure 5b. Note also intense activity of SVMs at ventricle 
(red line) suggestive of phagocytosis of ependymal cell debris. Each frame 
is a 2D projection representing a stack of 6 images 8 µm apart taken every 
90 seconds. Original magnification, 40×.
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